Literature DB >> 3701119

Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi.

A Kantele, H Arvilommi, I Jokinen.   

Abstract

Studies on intestinal immunity in animals have suggested that lymphocytes, after sensitization in Peyer's patches and maturation in regional lymph nodes, home via the circulation to the intestinal wall, where they secrete antibodies into the lumen. To detect such homing cells in the blood of human volunteers given oral, attenuated Salmonella typhi vaccine, we used the solid-phase enzyme-linked immunospot assay for S. typhi-specific antibody-secreting cells (ASCs). ASCs were found in eight of 10 individuals after the third postvaccination day, peaked in level on day 7, and were undetectable on day 14. Of the cells secreting specific immunoglobulin, approximately 62% produced IgA, 32% IgM, and 6% IgG. Antibodies could not be demonstrated in serum, saliva, or feces. This technique might give an opportunity to follow the response to antigens entering the body via mucous membranes. It will be of interest to correlate these findings with protection against diseases after peroral vaccination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701119     DOI: 10.1093/infdis/153.6.1126

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine.

Authors:  B D Forrest
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Comparison of the antibodies in lymphocyte supernatant and antibody-secreting cell assays for measuring intestinal mucosal immune response to a novel oral typhoid vaccine (M01ZH09).

Authors:  B D Kirkpatrick; Matthew D Bentley; Anette M Thern; Catherine J Larsson; Cassandra Ventrone; Meera V Sreenivasan; Lou Bourgeois
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.

Authors:  C Wennerås; A M Svennerholm; C Ahrén; C Czerkinsky
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans.

Authors:  A Kantele; M Häkkinen; Z Moldoveanu; A Lu; E Savilahti; R D Alvarez; S Michalek; J Mestecky
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.

Authors:  N Toida; G Hajishengallis; H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 7.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

8.  Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.

Authors:  M W Russell; Z Moldoveanu; P L White; G J Sibert; J Mestecky; M Michalek S
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

10.  Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.

Authors:  S Ghaem-Maghami; G Ratti; M Ghaem-Maghami; M Comanducci; P E Hay; R L Bailey; D C W Mabey; H C Whittle; M E Ward; D J M Lewis
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.